Millendo Therapeutics, Inc. (MLND): Price and Financial Metrics
MLND Stock Summary
- Millendo Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 7.5% of US listed stocks.
- With a year-over-year growth in debt of 570.28%, Millendo Therapeutics Inc's debt growth rate surpasses 96.28% of about US stocks.
- As for revenue growth, note that MLND's revenue has grown -150.17% over the past 12 months; that beats the revenue growth of only 0.32% of US companies in our set.
- MLND's SEC filings can be seen here. And to visit Millendo Therapeutics Inc's official web site, go to www.ovascience.com.
MLND Stock Price Chart Interactive Chart >
MLND Price/Volume Stats
|Current price||$2.16||52-week high||$9.67|
|Prev. close||$2.06||52-week low||$1.26|
|Day high||$2.20||Avg. volume||827,243|
|50-day MA||$2.12||Dividend yield||N/A|
|200-day MA||$1.89||Market Cap||41.04M|
Millendo Therapeutics, Inc. (MLND) Company Bio
Millendo Therapeutics, Inc. provides health care services. The Company develops treatments for endocrine diseases. Millendo Therapeutics serves customers in the United States and France.
MLND Latest News Stream
|Loading, please wait...|
MLND Latest Social Stream
View Full MLND Social Stream
Latest MLND News From Around the Web
Below are the latest news stories about Millendo Therapeutics Inc that investors may wish to consider to help them evaluate MLND as an investment opportunity.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Millendo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]
Millendo Therapeutics Provides Corporate and Pipeline Update.
MLND Price Returns
Continue Researching MLNDWant to see what other sources are saying about Millendo Therapeutics Inc's financials and stock price? Try the links below:
Millendo Therapeutics Inc (MLND) Stock Price | Nasdaq
Millendo Therapeutics Inc (MLND) Stock Quote, History and News - Yahoo Finance
Millendo Therapeutics Inc (MLND) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!